Concepedia

Natural product based inhibitors of the thioredoxin–thioredoxin reductase system

Peter Wipf, Stephen M. Lynch, Anne Birmingham, Giselle Tamayo‐Castillo, A. Sánchez Jiménez, Nefertiti Campos, Garth Powis

Organic & Biomolecular Chemistry · 2004 · 66 citations · 27 references

DOI

Concepts

Abstract

Spiroketal naphthodecalins are readily assembled by Barton's base mediated Ullmann binaphthyl ether coupling, Dakin reactions and hypervalent iodine spirocyclization. The core structures can be further diversified by enone addition and Stille coupling reactions. Nanomolar inhibitors for the Trx/TrxR redox control system were prepared by this approach and compared to series of natural product isolates. Cytotoxicity in MCF-7 cell assays ranged from an IC50 of 1.6 to >100 microM.

References

27

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Michael C. Alley, Dominic A. Scudiero, Anne Monks et al. · PubMed · 1988 · 3.1K citations

, , +14

Human Placenta Thioredoxin Reductase

Stephan Gromer, L. David Arscott, Charles H. Williams et al. · Journal of Biological Chemistry · 1998 · 535 citations · Full text

, , +15

The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.

Sarah J. Welsh, William Bellamy, Margaret M. Briehl et al. · PubMed · 2002 · 349 citations

, , +17

Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.

Margareta Berggren, Alfred Gallegos, John R. Gasdaska et al. · PubMed · 1997 · 309 citations

, , +11

The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.

Sarah J. Welsh, Ryan Williams, Anne Birmingham et al. · PubMed · 2003 · 252 citations

, , +17